Skip to main content

letter

. 1996 Jul 6;313(7048):45–46. doi: 10.1136/bmj.313.7048.45b

Directly observed treatment for tuberculosis. Treatment strategies will need to be changed because of drug resistance.

J S Friedland, G I Simoes

PMCID: PMC2351422 PMID: 8664785

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bhatti N., Law M. R., Morris J. K., Halliday R., Moore-Gillon J. Increasing incidence of tuberculosis in England and Wales: a study of the likely causes. BMJ. 1995 Apr 15;310(6985):967–969. doi: 10.1136/bmj.310.6985.967. [DOI] [PMC free article] [PubMed] [Google Scholar]
Frieden T. R., Sterling T., Pablos-Mendez A., Kilburn J. O., Cauthen G. M., Dooley S. W. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med. 1993 Feb 25;328(8):521–526. doi: 10.1056/NEJM199302253280801. [DOI] [PubMed] [Google Scholar]
Heym B., Honoré N., Truffot-Pernot C., Banerjee A., Schurra C., Jacobs W. R., Jr, van Embden J. D., Grosset J. H., Cole S. T. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet. 1994 Jul 30;344(8918):293–298. doi: 10.1016/s0140-6736(94)91338-2. [DOI] [PubMed] [Google Scholar]
Morse D. I. Directly observed therapy for tuberculosis. BMJ. 1996 Mar 23;312(7033):719–720. doi: 10.1136/bmj.312.7033.719. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES